+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Did de novo MELAS common mitochondrial DNA point mutation (mtDNA 3243, A-->G transition) occur in the mother of a proband of a Japanese MELAS pedigree?



Did de novo MELAS common mitochondrial DNA point mutation (mtDNA 3243, A-->G transition) occur in the mother of a proband of a Japanese MELAS pedigree?



Journal of the Neurological Sciences 135(1): 81-84



MELAS is a major maternally inherited mitochondrial (mt) encephalomyopathy of which 80% of cases are associated with mtDNA point mutation (mtDNA 3243, A-->G transition) which exists under heteroplasmic conditions with wild-type mtDNA. The origin of this mutation remains obscure in the reported pedigrees. I analyzed this mutation in a Japanese MELAS pedigree by PCR. The proband had typical MELAS features. The proband's mother was oligosymptomatic (fatigability, nerve deafness and diabetes mellitus). The proband's maternal grandmother was diagnosed as having senile dementia of the Alzheimer type clinically. The brother of the proband's mother was healthy. The ratios of this mutation in muscle and leukocytes of the proband and his mother were 89%, 36%, 79% and 10%, respectively. There were no mutations in muscle and leukocytes of the proband's maternal grandmother and his mother's brother. These results showed the possibility that this mutation occurred in the proband's mother.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045777129

Download citation: RISBibTeXText

PMID: 8926502


Related references

MELAS with the mitochondrial DNA 3243 point mutation: A neuropathological study. Acta Neuropathologica 99(1): 31-38, 2000

Mitochondrial maculopathy: Geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation. American Journal of Ophthalmology 128(1): 112-114, 1999

Quantification of tRna 3243 Leu point mutation of mitochondrial Dna in Melas patients and its effects on mitochondrial transcription. Human Molecular Genetics 2(5): 525-534, 1993

Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology. 100(12): 1757-1766, 1993

The 3243 MELAS mutation in a pedigree with MERRF. European Neurology 35(3): 168-171, 1995

Pathogenetic mechanism of the 3243 MELAS mtDNA mutation. American Journal of Human Genetics 61(4 Suppl. ): A306, 1997

Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. American Journal of Human Genetics 68(1): 238-240, 2001

Decrease of 3243 A- >G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. American Journal of Human Genetics 68(1): 8-40, 2001

Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS. Nucleic Acids Research 21(3): 657-662, 1993

High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families. Cephalalgia 30(8): 919-927, 2010

Pathophysiology of the MELAS 3243 transition mutation. Journal of Biological Chemistry 272(43): 27189-27196, 1997

The study of nt 3243 point mutation in Turkish MELAS patients. European Journal of Human Genetics 4(Suppl. 1): 79, 1996

Mitochondrial 3243 A-->G mutation (MELAS mutation) associated with painful muscle stiffness. Neuromuscular Disorders 9(5): 305-307, 1999

MERRF/MELAS overlap syndrome associated with 3243 tRNALeu(UUR) mutation of mitochondrial DNA. Neuropathology 18(3): 321-327, 1998

Maternally inherited cardiomyopathy: A new phenotype associated with the A to G at nt.3243 of mitochondrial DNA (MELAS mutation). Muscle and Nerve 20(2): 221-225, 1997